Scott Gottlieb is the Deputy Commissioner for Medical and Scientific Affairs at the U.S. Food and Drug Administration and a former senior official at the Centers for Medicare and Medicaid Services. As the FDA’s Deputy Commissioner for Medical and Scientific Affairs, Dr. Gottlieb is a senior advisor to Acting Commissioner, Dr. Andrew von Eschenbach, on all major agency matters including regulations, policy and administrative programs. His office works with all of the FDA’s centers on implementing and coordinating the agency’s regulatory and administrative policies aimed at advancing the public health. From 2003-2004, Dr. Gottlieb served as a senior advisor to the FDA Commissioner and as the Agency’s Director of Medical Policy Development, leaving in the spring of 2004 to work on implementation of the new Medicare Drug Benefit as a Senior Adviser to the Administrator of Medicare and Medicaid Services. Dr. Gottlieb’s research focuses on health policy, medical technology, and on seeking improvements in the public’s health through innovation in technology, medical practice, and healthcare delivery. He received his MD from the Mount Sinai School of Medicine.
Science and Politics: FDA Perspective Prof. Kurt Gottfried, PhD U.S. Food and Drug Administration Thursday, April 12, 2007 12:15am - 1:30pm Coffman Memorial Union Theater This lecture will describe the role of science in federal agency policymaking and recent controversies that have arisen in the FDA, such as the debate surrounding medical devices recalls. Following this lecture, participants should be able to: Discuss FDA regulations and policy affecting food, drugs, and devices. Understand FDA methods of responding to controversies and criticisms from health professionals and the public. Application for CME and CNE Credits filed with the University of Minnesota Office of Continuing Medical Education. Determination of credit is pending. Credit is sought only for those attending the live lecture; credit will not be given for viewing videotapes after the lecture. Continuing legal education credit (CLE) for attorneys will be requested (1.5 hours). It is the policy of the University of Minnesota’s Office of Continuing Medical Education to ensure balance, independence, objectivity and scientific rigor in all its sponsored educational activities. All faculty participating in sponsored programs are expected to disclose to the program audience any real or apparent conflict of interest related to the content of their presentation.